Ignite Creation Date:
2025-12-24 @ 6:51 PM
Ignite Modification Date:
2026-01-01 @ 2:29 AM
Study NCT ID:
NCT05979857
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-11-22
First Post:
2023-07-31
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of SP-3164 in Relapsed or Refractory Non-Hodgkin's Lymphoma
Sponsor:
Salarius Pharmaceuticals, LLC
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
SALA-003-NHL
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None